Portfolio Holdings Detail for ISIN IE00BMWPV470
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)
Issuer Blackrock

ETF Ticker SUAP(GBP) LSE
ETF Ticker SUAP.LS(GBP) CXE
ETF Ticker SUAP.L(GBP) LSE

Holdings detail for RPRX

Stock Name	Royalty Pharma Plc
Ticker	RPRX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	GB00BMVP7Y09
LEI	549300FGFN7VOK8BZR03

Show aggregate RPRX holdings

News associated with RPRX

Royalty Pharma Expects At Least Mid-teens Average Annual Total Shareholder Return Over 2025-2030.: (RTTNews) - Royalty Pharma plc (RPRX) Thursday said it will host an Investor Day today, where senior executives will provide updates on the company's strategies aimed at driving shareholder value creation. - 2025-09-11 08:35:29
Maryland State Retirement & Pension System Trims Stock Position in Royalty Pharma PLC (NASDAQ:RPRX): Maryland State Retirement & Pension System lessened its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 18.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,291 shares of the biopharmaceutical company’s stock after selling 4,133 shares during the quarter. […] - 2025-08-15 05:22:58
PNC Financial Services Group Inc. Acquires 859 Shares of Royalty Pharma PLC (NASDAQ:RPRX): PNC Financial Services Group Inc. boosted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 7.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,665 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-08-15 04:48:59
Blair William & Co. IL Invests $212,000 in Royalty Pharma PLC (NASDAQ:RPRX): Blair William & Co. IL bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,801 shares of the biopharmaceutical company’s stock, valued at approximately $212,000. A number of other hedge […] - 2025-08-13 07:56:48
Deutsche Bank AG Sells 1,775,038 Shares of Royalty Pharma PLC (NASDAQ:RPRX): Deutsche Bank AG lessened its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 55.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 1,414,926 shares of the biopharmaceutical company’s stock after selling 1,775,038 shares during the period. Deutsche Bank AG’s holdings in Royalty Pharma were worth $44,047,000 as of its most recent […] - 2025-08-13 05:54:50
Charles Schwab Investment Management Inc. Has $97.20 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX): Charles Schwab Investment Management Inc. cut its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 0.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,122,531 shares of the biopharmaceutical company’s stock after selling 9,097 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Royalty Pharma were worth $97,204,000 as […] - 2025-08-13 05:10:46
Royalty Pharma (NASDAQ:RPRX) Raised to Buy at Wall Street Zen: Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other equities research analysts also recently weighed in on the company. Morgan Stanley boosted their target price on Royalty Pharma from $51.00 […] - 2025-08-11 03:50:55
Allianz Asset Management GmbH Has $6.03 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX): Allianz Asset Management GmbH reduced its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 64.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 193,591 shares of the biopharmaceutical company’s stock after selling 356,968 shares during the period. Allianz […] - 2025-07-28 07:00:47
Edgestream Partners L.P. Invests $659,000 in Royalty Pharma PLC (NASDAQ:RPRX): Edgestream Partners L.P. acquired a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,158 shares of the biopharmaceutical company’s stock, valued at approximately $659,000. Other hedge funds and other institutional investors also […] - 2025-07-20 05:24:59
Cerity Partners LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX): Cerity Partners LLC raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 786.3% during the 1st quarter, Holdings Channel reports. The fund owned 153,846 shares of the biopharmaceutical company’s stock after purchasing an additional 136,487 shares during the period. Cerity Partners LLC’s holdings in Royalty Pharma were worth $4,789,000 as […] - 2025-07-17 05:00:57
Xponance Inc. Acquires 1,437 Shares of Royalty Pharma PLC (NASDAQ:RPRX): Xponance Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 3.7% in the first quarter, HoldingsChannel.com reports. The firm owned 40,133 shares of the biopharmaceutical company’s stock after buying an additional 1,437 shares during the period. Xponance Inc.’s holdings in Royalty Pharma were worth $1,249,000 as of its most […] - 2025-07-16 05:48:56
M&T Bank Corp Buys 5,500 Shares of Royalty Pharma PLC (NASDAQ:RPRX): M&T Bank Corp raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 23.4% in the 1st quarter, Holdings Channel reports. The firm owned 28,967 shares of the biopharmaceutical company’s stock after acquiring an additional 5,500 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $902,000 at […] - 2025-07-15 06:23:30
Teacher Retirement System of Texas Cuts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX): Teacher Retirement System of Texas cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 10.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,364 shares of the biopharmaceutical company’s stock after selling 12,028 shares during the […] - 2025-07-09 05:33:01
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX): Allspring Global Investments Holdings LLC boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 561,724 shares of the biopharmaceutical company’s stock after acquiring an additional 21,729 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Royalty […] - 2025-07-03 06:09:03
11,210 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by Kentucky Retirement Systems Insurance Trust Fund: Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 11,210 shares of the biopharmaceutical company’s stock, valued at approximately $349,000. Other hedge funds also recently bought and sold shares of the company. Louisbourg Investments Inc. […] - 2025-06-26 05:42:57
After Hours Most Active for Jun 24, 2025 : SNAP, NVDA, CMCSA, PLTR, INTC, SPR, AUR, RPRX, KVUE, MPW, GM, WMT: The NASDAQ 100 After Hours Indicator is down -.81 to 22,189.71. The total After hours volume is currently 173,627,396 shares traded.The following are the most active stocks for the after hours session: Snap Inc. (SNAP) is unchanged at $8.32, with 14,501,942 shares traded. SNAP's - 2025-06-24 17:24:56
Manning & Napier Advisors LLC Sells 44,505 Shares of Royalty Pharma PLC (NASDAQ:RPRX): Manning & Napier Advisors LLC lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 54.9% during the first quarter, HoldingsChannel.com reports. The firm owned 36,549 shares of the biopharmaceutical company’s stock after selling 44,505 shares during the quarter. Manning & Napier Advisors LLC’s holdings in Royalty Pharma were worth $1,138,000 […] - 2025-06-24 05:20:57
After Hours Most Active for Jun 11, 2025 : PLTR, NVDA, AMZN, AAPL, RPRX, MCHPP: The NASDAQ 100 After Hours Indicator is up 14.32 to 21,875.12. The total After hours volume is currently 131,070,110 shares traded.The following are the most active stocks for the after hours session: Palantir Technologies Inc. (PLTR) is +0.25 at $136.64, with 5,538,416 shares t - 2025-06-11 17:24:56
Rhumbline Advisers Has $14.01 Million Position in Royalty Pharma plc (NASDAQ:RPRX): Rhumbline Advisers lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The firm owned 449,964 shares of the biopharmaceutical company’s stock after selling 4,184 shares during the quarter. Rhumbline Advisers’ holdings in Royalty Pharma were worth $14,007,000 as of its most recent SEC […] - 2025-06-09 05:24:51
Lazard Asset Management LLC Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX): Lazard Asset Management LLC lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the biopharmaceutical company’s stock after selling 1,130 shares during the quarter. Lazard Asset […] - 2025-05-22 05:46:49
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Buy” from Brokerages: Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. […] - 2025-05-22 04:50:51
Captrust Financial Advisors Sells 14,499 Shares of Royalty Pharma plc (NASDAQ:RPRX): Captrust Financial Advisors reduced its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 49.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,829 shares of the biopharmaceutical company’s stock after selling 14,499 shares during the quarter. Captrust Financial Advisors’ holdings in Royalty Pharma were worth $378,000 as of […] - 2025-05-20 04:52:44
Analysts Predict 10% Gains Ahead For The Holdings of EUSA: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:59:43
Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com: Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Citigroup reiterated a “buy” rating on shares of Royalty Pharma in a research report on Friday, March 28th. One equities research analyst has rated […] - 2025-05-14 02:14:45
Stifel Financial Corp Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX): Stifel Financial Corp reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 11.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,152 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the period. Stifel Financial Corp’s holdings in Royalty Pharma were worth $438,000 at the end […] - 2025-05-13 04:50:58
Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX): Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 05:01:02
American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX): American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 04:26:56
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.: JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 04:44:55
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX): Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 05:29:08
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60: Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 02:14:52

iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist) RPRX holdings

Date	Number of RPRX Shares Held	Base Market Value of RPRX Shares	Local Market Value of RPRX Shares	Change in RPRX Shares Held	Change in RPRX Base Value	Current Price per RPRX Share Held	Previous Price per RPRX Share Held
2026-01-16 (Friday)	108,517	USD 4,291,847	USD 4,291,847	0	USD -18,448	USD 39.55	USD 39.72
2026-01-15 (Thursday)	108,517	USD 4,310,295	USD 4,310,295	-87	USD -56,672	USD 39.72	USD 40.21
2026-01-14 (Wednesday)	108,604	USD 4,366,967	USD 4,366,967	0	USD -16,290	USD 40.21	USD 40.36
2026-01-13 (Tuesday)	108,604	USD 4,383,257	USD 4,383,257	0	USD 10,860	USD 40.36	USD 40.26
2026-01-12 (Monday)	108,604	USD 4,372,397	USD 4,372,397	-522	USD -11,194	USD 40.26	USD 40.17
2026-01-09 (Friday)	109,126	USD 4,383,591	USD 4,383,591	-87	USD -13,324	USD 40.17	USD 40.26
2026-01-08 (Thursday)	109,213	USD 4,396,915	USD 4,396,915	0	USD -123,411	USD 40.26	USD 41.39
2026-01-07 (Wednesday)	109,213	USD 4,520,326	USD 4,520,326	-905	USD 44,029	USD 41.39	USD 40.65
2026-01-06 (Tuesday)	110,118	USD 4,476,297	USD 4,476,297	0	USD 110,118	USD 40.65	USD 39.65
2026-01-05 (Monday)	110,118	USD 4,366,179	USD 4,366,179	0	USD 86,994	USD 39.65	USD 38.86
2026-01-02 (Friday)	110,118	USD 4,279,185	USD 4,279,185	87	USD 27,587	USD 38.86	USD 38.64

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RPRX by Blackrock for IE00BMWPV470

Show aggregate share trades of RPRX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 SELL -87 40.335 39.560 39.638 USD -3,448 37.32 Loss of -201 on sale
2026-01-12 SELL -522 40.430 39.990 40.034 USD -20,898 37.24 Loss of -1,458 on sale
2026-01-09 SELL -87 40.980 40.135 40.219 USD -3,499 37.21 Loss of -261 on sale
2026-01-07 SELL -905 41.405 40.640 40.716 USD -36,848 37.15 Loss of -3,231 on sale
2026-01-02 BUY 87 38.875 38.290 38.349 USD 3,336 37.07
2025-12-31 SELL -267 39.160 38.600 38.656 USD -10,321 37.06 Loss of -427 on sale
2025-12-31 SELL -267 39.160 38.600 38.656 USD -10,321 37.06 Loss of -427 on sale
2025-12-23 BUY 435 39.499 38.650 38.735 USD 16,850 36.95
2025-12-22 SELL -522 38.880 38.440 38.484 USD -20,089 36.93 Loss of -813 on sale
2025-12-19 SELL -174 38.805 38.200 38.261 USD -6,657 36.91 Loss of -235 on sale
2025-12-18 SELL -95 38.690 38.280 38.321 USD -3,640 36.89 Loss of -136 on sale
2025-12-17 SELL -530 38.895 38.300 38.359 USD -20,331 36.88 Loss of -786 on sale
2025-12-16 SELL -258 38.665 37.830 37.914 USD -9,782 36.86 Loss of -272 on sale
2025-12-12 SELL -174 38.930 37.975 38.070 USD -6,624 36.83 Loss of -217 on sale
2025-12-08 SELL -1,305 39.780 38.600 38.718 USD -50,527 36.75 Loss of -2,569 on sale
2025-12-04 BUY 2,687 39.640 38.980 39.046 USD 104,917 36.69
2025-11-28 SELL -353 40.070 39.650 39.692 USD -14,011 36.53 Loss of -1,116 on sale
2025-11-25 SELL -957 40.000 39.270 39.343 USD -37,651 36.41 Loss of -2,810 on sale
2025-11-24 BUY 6,096 39.830 37.310 37.562 USD 228,978 36.36
2025-11-20 SELL -172 38.850 38.080 38.157 USD -6,563 36.30 Loss of -319 on sale
2025-11-19 SELL -249 39.690 37.770 37.962 USD -9,453 36.27 Loss of -422 on sale
2025-11-18 SELL -415 39.510 38.985 39.038 USD -16,201 36.22 Loss of -1,168 on sale
2025-11-14 SELL -498 39.645 38.820 38.902 USD -19,373 36.14 Loss of -1,376 on sale
2025-11-12 SELL -2,490 40.000 38.920 39.028 USD -97,180 36.04 Loss of -7,449 on sale
2025-11-10 SELL -168 39.399 38.510 38.599 USD -6,485 35.95 Loss of -444 on sale
2025-11-07 SELL -83 40.100 38.390 38.561 USD -3,201 35.91 Loss of -220 on sale
2025-11-05 SELL -166 40.815 36.027 36.506 USD -6,060 35.77 Loss of -123 on sale
2025-10-29 SELL -574 36.670 36.980 36.949 USD -21,209 35.64 Loss of -753 on sale
2025-10-23 SELL -164 36.850 37.160 37.129 USD -6,089 35.54 Loss of -261 on sale
2025-10-21 SELL -164 37.480 37.520 37.516 USD -6,153 35.48 Loss of -334 on sale
2025-10-16 SELL -82 36.340 36.450 36.439 USD -2,988 35.40 Loss of -85 on sale
2025-10-14 SELL -328 36.000 36.130 36.117 USD -11,846 35.38 Loss of -243 on sale
2025-10-07 SELL -164 36.100 36.480 36.442 USD -5,976 35.36 Loss of -177 on sale
2025-09-26 SELL -164 35.040 35.220 35.202 USD -5,773 35.28 Profit of 13 on sale
2025-09-24 SELL -164 35.770 36.435 36.369 USD -5,964 35.28 Loss of -179 on sale
2025-09-18 SELL -164 35.730 35.810 35.802 USD -5,872 35.27 Loss of -88 on sale
2025-09-10 BUY 164 36.180 36.760 36.702 USD 6,019 35.18
2025-08-21 SELL -316 36.310 36.900 36.841 USD -11,642 35.05 Loss of -565 on sale
2025-08-20 SELL -395 36.880 36.890 36.889 USD -14,571 34.99 Loss of -751 on sale
2025-07-10 BUY 474 36.120 36.560 36.516 USD 17,309 34.94
2025-07-09 SELL -395 35.870 35.900 35.897 USD -14,179 34.91 Loss of -390 on sale
2025-07-08 SELL -2,172 35.510 35.910 35.870 USD -77,910 34.89 Loss of -2,139 on sale
2025-06-27 SELL -1,027 35.870 35.931 35.925 USD -36,895 34.51 Loss of -1,452 on sale
2025-06-26 SELL -79 35.270 36.140 36.053 USD -2,848 34.47 Loss of -125 on sale
2025-06-24 SELL -256 36.140 36.320 36.302 USD -9,293 34.27 Loss of -519 on sale
2025-06-20 SELL -1,629 34.860 34.890 34.887 USD -56,831 34.15 Loss of -1,197 on sale
2025-06-17 SELL -3,343 34.560 35.140 35.082 USD -117,279 33.98 Loss of -3,693 on sale
2025-06-13 SELL -395 34.840 35.380 35.326 USD -13,954 33.76 Loss of -620 on sale
2025-06-12 BUY 385 35.270 35.370 35.360 USD 13,614 33.57
2025-06-09 SELL -869 33.390 33.860 33.813 USD -29,383 33.50 Loss of -269 on sale
2025-06-06 SELL -234 33.780 33.970 33.951 USD -7,945 33.43 Loss of -121 on sale
2025-06-04 SELL -1,501 33.440 33.715 33.688 USD -50,565 33.27 Loss of -619 on sale
2025-06-03 SELL -395 33.290 33.540 33.515 USD -13,238 33.26 Loss of -101 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	SELL	-87	40.335	39.560	39.638	USD -3,448	37.32 Loss of -201 on sale
2026-01-12	SELL	-522	40.430	39.990	40.034	USD -20,898	37.24 Loss of -1,458 on sale
2026-01-09	SELL	-87	40.980	40.135	40.219	USD -3,499	37.21 Loss of -261 on sale
2026-01-07	SELL	-905	41.405	40.640	40.716	USD -36,848	37.15 Loss of -3,231 on sale
2026-01-02	BUY	87	38.875	38.290	38.349	USD 3,336	37.07
2025-12-31	SELL	-267	39.160	38.600	38.656	USD -10,321	37.06 Loss of -427 on sale
2025-12-31	SELL	-267	39.160	38.600	38.656	USD -10,321	37.06 Loss of -427 on sale
2025-12-23	BUY	435	39.499	38.650	38.735	USD 16,850	36.95
2025-12-22	SELL	-522	38.880	38.440	38.484	USD -20,089	36.93 Loss of -813 on sale
2025-12-19	SELL	-174	38.805	38.200	38.261	USD -6,657	36.91 Loss of -235 on sale
2025-12-18	SELL	-95	38.690	38.280	38.321	USD -3,640	36.89 Loss of -136 on sale
2025-12-17	SELL	-530	38.895	38.300	38.359	USD -20,331	36.88 Loss of -786 on sale
2025-12-16	SELL	-258	38.665	37.830	37.914	USD -9,782	36.86 Loss of -272 on sale
2025-12-12	SELL	-174	38.930	37.975	38.070	USD -6,624	36.83 Loss of -217 on sale
2025-12-08	SELL	-1,305	39.780	38.600	38.718	USD -50,527	36.75 Loss of -2,569 on sale
2025-12-04	BUY	2,687	39.640	38.980	39.046	USD 104,917	36.69
2025-11-28	SELL	-353	40.070	39.650	39.692	USD -14,011	36.53 Loss of -1,116 on sale
2025-11-25	SELL	-957	40.000	39.270	39.343	USD -37,651	36.41 Loss of -2,810 on sale
2025-11-24	BUY	6,096	39.830	37.310	37.562	USD 228,978	36.36
2025-11-20	SELL	-172	38.850	38.080	38.157	USD -6,563	36.30 Loss of -319 on sale
2025-11-19	SELL	-249	39.690	37.770	37.962	USD -9,453	36.27 Loss of -422 on sale
2025-11-18	SELL	-415	39.510	38.985	39.038	USD -16,201	36.22 Loss of -1,168 on sale
2025-11-14	SELL	-498	39.645	38.820	38.902	USD -19,373	36.14 Loss of -1,376 on sale
2025-11-12	SELL	-2,490	40.000	38.920	39.028	USD -97,180	36.04 Loss of -7,449 on sale
2025-11-10	SELL	-168	39.399	38.510	38.599	USD -6,485	35.95 Loss of -444 on sale
2025-11-07	SELL	-83	40.100	38.390	38.561	USD -3,201	35.91 Loss of -220 on sale
2025-11-05	SELL	-166	40.815	36.027	36.506	USD -6,060	35.77 Loss of -123 on sale
2025-10-29	SELL	-574	36.670	36.980	36.949	USD -21,209	35.64 Loss of -753 on sale
2025-10-23	SELL	-164	36.850	37.160	37.129	USD -6,089	35.54 Loss of -261 on sale
2025-10-21	SELL	-164	37.480	37.520	37.516	USD -6,153	35.48 Loss of -334 on sale
2025-10-16	SELL	-82	36.340	36.450	36.439	USD -2,988	35.40 Loss of -85 on sale
2025-10-14	SELL	-328	36.000	36.130	36.117	USD -11,846	35.38 Loss of -243 on sale
2025-10-07	SELL	-164	36.100	36.480	36.442	USD -5,976	35.36 Loss of -177 on sale
2025-09-26	SELL	-164	35.040	35.220	35.202	USD -5,773	35.28 Profit of 13 on sale
2025-09-24	SELL	-164	35.770	36.435	36.369	USD -5,964	35.28 Loss of -179 on sale
2025-09-18	SELL	-164	35.730	35.810	35.802	USD -5,872	35.27 Loss of -88 on sale
2025-09-10	BUY	164	36.180	36.760	36.702	USD 6,019	35.18
2025-08-21	SELL	-316	36.310	36.900	36.841	USD -11,642	35.05 Loss of -565 on sale
2025-08-20	SELL	-395	36.880	36.890	36.889	USD -14,571	34.99 Loss of -751 on sale
2025-07-10	BUY	474	36.120	36.560	36.516	USD 17,309	34.94
2025-07-09	SELL	-395	35.870	35.900	35.897	USD -14,179	34.91 Loss of -390 on sale
2025-07-08	SELL	-2,172	35.510	35.910	35.870	USD -77,910	34.89 Loss of -2,139 on sale
2025-06-27	SELL	-1,027	35.870	35.931	35.925	USD -36,895	34.51 Loss of -1,452 on sale
2025-06-26	SELL	-79	35.270	36.140	36.053	USD -2,848	34.47 Loss of -125 on sale
2025-06-24	SELL	-256	36.140	36.320	36.302	USD -9,293	34.27 Loss of -519 on sale
2025-06-20	SELL	-1,629	34.860	34.890	34.887	USD -56,831	34.15 Loss of -1,197 on sale
2025-06-17	SELL	-3,343	34.560	35.140	35.082	USD -117,279	33.98 Loss of -3,693 on sale
2025-06-13	SELL	-395	34.840	35.380	35.326	USD -13,954	33.76 Loss of -620 on sale
2025-06-12	BUY	385	35.270	35.370	35.360	USD 13,614	33.57
2025-06-09	SELL	-869	33.390	33.860	33.813	USD -29,383	33.50 Loss of -269 on sale
2025-06-06	SELL	-234	33.780	33.970	33.951	USD -7,945	33.43 Loss of -121 on sale
2025-06-04	SELL	-1,501	33.440	33.715	33.688	USD -50,565	33.27 Loss of -619 on sale
2025-06-03	SELL	-395	33.290	33.540	33.515	USD -13,238	33.26 Loss of -101 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RPRX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	877,435	0	1,269,348	69.1%
2025-09-18	854,156	255	1,225,709	69.7%
2025-09-17	890,428	0	1,130,889	78.7%
2025-09-16	849,691	0	1,371,042	62.0%
2025-09-15	1,310,051	875	1,800,476	72.8%
2025-09-12	1,066,120	800	1,339,292	79.6%
2025-09-11	1,220,120	283	1,532,656	79.6%
2025-09-10	1,195,119	790	1,440,333	83.0%
2025-09-09	1,259,853	924	1,521,804	82.8%
2025-09-08	1,967,280	1,094	3,312,547	59.4%
2025-09-05	2,792,926	0	4,789,487	58.3%
2025-09-04	649,497	0	1,396,642	46.5%
2025-09-03	741,511	0	3,964,244	18.7%
2025-09-02	1,164,461	621	1,836,122	63.4%
2025-08-29	568,848	644	1,099,441	51.7%
2025-08-28	343,443	1,229	665,672	51.6%
2025-08-27	718,529	15	1,134,797	63.3%
2025-08-26	376,806	3,158	782,116	48.2%
2025-08-25	523,360	0	1,666,116	31.4%
2025-08-22	416,975	1,403	983,556	42.4%
2025-08-21	515,906	1	789,605	65.3%
2025-08-20	668,934	557	1,359,619	49.2%
2025-08-19	282,363	1,211	801,139	35.2%
2025-08-18	470,777	713	735,143	64.0%
2025-08-15	370,886	0	849,955	43.6%
2025-08-14	437,271	0	1,270,825	34.4%
2025-08-13	450,930	0	2,187,219	20.6%
2025-08-12	378,708	321	1,366,736	27.7%
2025-08-11	566,603	322	1,321,771	42.9%
2025-08-08	732,304	1,141	1,058,552	69.2%
2025-08-07	637,779	141	1,478,119	43.1%
2025-08-06	968,026	95	1,335,306	72.5%
2025-08-05	817,147	97	1,153,956	70.8%
2025-08-04	562,562	677	830,964	67.7%
2025-08-01	356,771	847	641,246	55.6%
2025-07-31	550,713	210	657,912	83.7%
2025-07-30	529,655	432	816,351	64.9%
2025-07-29	600,859	25	752,372	79.9%
2025-07-28	682,728	1,073	824,975	82.8%
2025-07-25	351,993	50	514,201	68.5%
2025-07-24	396,410	57	557,229	71.1%
2025-07-23	289,217	2,996	787,220	36.7%
2025-07-22	460,421	0	666,171	69.1%
2025-07-21	489,845	1,682	693,054	70.7%
2025-07-18	355,376	0	587,434	60.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)
Issuer	Blackrock
ETF Ticker	SUAP(GBP) LSE
ETF Ticker	SUAP.LS(GBP) CXE
ETF Ticker	SUAP.L(GBP) LSE